InsiderTrades

Form 4 for INO INOVIO PHARMACEUTICALS, INC.

Accepted 2024-07-01 00:00:00 ET · period of report 2024-06-30 · accession 0001055726-24-000042 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-07-01 2024-06-30 INO Sumner Michael John Chief Medical Off M - OptEx — +2,917 8,219 +55% —
D 2024-07-01 2024-06-30 INO Sumner Michael John Chief Medical Off M - OptEx $0.00 -2,917 2,916 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-30 M A 2,917 — 8,219 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 8,749 restricted stock units is as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares will vest on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.
2 Derivative Restricted Stock Unit 2024-06-30 M D 2,917 $0.00 2,916 D — · — to — 2,917 Common Stock (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 8,749 restricted stock units is as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares will vest on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.